Advertisement
Canada markets open in 1 hour 26 minutes

  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     

  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     

  • DOW

    37,775.38
    +22.07 (+0.06%)
     

  • CAD/USD

    0.7265
    +0.0001 (+0.02%)
     

  • CRUDE OIL

    82.35
    -0.38 (-0.46%)
     

  • Bitcoin CAD

    89,297.35
    +3,010.85 (+3.49%)
     

  • CMC Crypto 200

    1,342.97
    +30.35 (+2.37%)
     

  • GOLD FUTURES

    2,392.60
    -5.40 (-0.23%)
     

  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     

  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,477.75
    -69.50 (-0.40%)
     

  • VOLATILITY

    18.83
    +0.83 (+4.61%)
     

  • FTSE

    7,837.18
    -39.87 (-0.51%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6818
    -0.0003 (-0.04%)
     

Is It Too Late to Buy ChemoCentryx Stock?

David Jagielski, The Motley Fool
·4 min read
Is It Too Late to Buy ChemoCentryx Stock?

The U.S. Food and Drug Administration (FDA) granted approval for the company's autoimmune drug, avacopan, which instantly led to shares of ChemoCentryx more than doubling in value. For investors who didn't want to take on the risk heading into the FDA decision, the obvious question now is whether it's too late to invest in the healthcare stock. After amassing such impressive returns over a short time frame, can investors who buy the stock today still expect to earn a good return on their investment?

Continue reading